Pharma News

A single dose of an experimental Ebola virus (EBOV) vaccine, currently undergoing testing in humans, completely protects monkeys against the current outbreak strain, when given at least seven days before exposure, scientists have found. The vaccine partially protects the cynomolgus macaques against the EBOV-Makona strain if given three days prior, researchers said.

With over 75 per cent of people in India being unaware about the existence of Hepatitis, the leading gastroenterologists of the country have decided to start an online data registry detailing the rising number of hepatitis patients. "The need of setting up a registry was felt as over 75 per cent of the people in India do not even know that a disease like hepatitis exists," said a senior doctor at AIIMS. "The aim is to keep a record of the number of people suffering from hepatitis and other liver diseases caused by it in the country," the doctor said.

Trivitron Healthcare, India’s largest medical technology company was honoured with 'Make In India Awards for Excellence' in the medical device manufacturing category.

[adsense:336x280:8701650588]

Eli Lilly and Company, a global healthcare leader, has launched
Humalog 200 units/ml KwikPen (insulin lispro 200 units/m; U-200), the first and only concentrated mealtime insulin analog in the US.

According to a study, consumption of hot  chillies can prevent overeating via an action on nerves in the stomach, thus curbing obesity in chilli lovers. The paper appeared in the journal PLOS ONE.

A new study has revealed that a regular dose of aspirin can reverse the bowel cancer in overweight people. The study is published in Journal of Clinical Oncology.

The researchers revealed that social factors such as a woman's education level and marital status before pregnancy can affect the birth weight of her daughters and granddaughters. The study findings tie social and biological factors together in determining causes for low birth weight. The study is published in the Journal of Health and Social Behavior.

A new study by researchers at Dana-Farber Cancer Center in Boston has revealed that drinking four or more cups of caffeinated coffee daily, or about 460 milligrams of caffeine, may significantly reduce the chances of recurrence of colon cancer in patients who were diagnosed with stage III of the disease. The study is published in the Journal of Clinical Oncology.

A new study has revealed potential new treatments which could help people with cognitive diseases. The study is published in Neuropsychopharmacology.

The study found that introduction of a new prescription smoking-cessation drug varenicline in 2006 has had no significant impact on the rate at which US adults successfully quit smoking. The study was published online in the journal Tobacco Control.